Stocks and Investing Stocks and Investing
Thu, June 20, 2024

Eliana Merle Downgraded (ZNTL) to Hold and Decreased Target to $5 on, Jun 20th, 2024


Published on 2024-10-28 12:00:51 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of UBS, Downgraded "Zentalis Pharmaceuticals, Inc." (ZNTL) to Hold and Decreased Target from $28 to $5 on, Jun 20th, 2024.

Eliana has made no other calls on ZNTL in the last 4 months.



There are 6 other peers that have a rating on ZNTL. Out of the 6 peers that are also analyzing ZNTL, 3 agree with Eliana's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $9 on, Tuesday, June 18th, 2024
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $8 on, Tuesday, June 18th, 2024
  • Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024


These are the ratings of the 3 analyists that currently disagree with Eliana


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, June 18th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, June 18th, 2024
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Tuesday, June 18th, 2024
Contributing Sources